Your browser doesn't support javascript.
loading
Pre-exposure prophylaxis (PrEP) uptake and service delivery adaptations during the first wave of the COVID-19 pandemic in 21 PEPFAR-funded countries.
Kerzner, Michael; De, Anindya K; Yee, Randy; Keating, Ryan; Djomand, Gaston; Stash, Sharon; Rana, Sangeeta; Kimmel, Allison; Eakle, Robyn; Klucking, Sara; Patel, Pragna.
Afiliação
  • Kerzner M; Science Unit, Center for State, Tribal, Local, and Territorial Support, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • De AK; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Yee R; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Keating R; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Djomand G; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Stash S; Department of International HIV Prevention and Testing, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
  • Rana S; Bureau for Global Health, Office of HIV/AIDS, United States Agency for International Development, Washington, DC, United States of America.
  • Kimmel A; Bureau for Global Health, Office of HIV/AIDS, United States Agency for International Development, Washington, DC, United States of America.
  • Eakle R; Bureau for Global Health, Office of HIV/AIDS, United States Agency for International Development, Washington, DC, United States of America.
  • Klucking S; Office of the U.S. Global AIDS Coordinator and Health Diplomacy, U.S. Department of State, Washington, DC, United States of America.
  • Patel P; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
PLoS One ; 17(4): e0266280, 2022.
Article em En | MEDLINE | ID: mdl-35381024
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Profilaxia Pré-Exposição / COVID-19 Limite: Adolescent / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Profilaxia Pré-Exposição / COVID-19 Limite: Adolescent / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article